CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 89 filers reported holding CTI BIOPHARMA CORP in Q2 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $0 | – | 253 | +8.6% | 0.00% | – |
| Q3 2016 | $0 | – | 233 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 233 | -99.7% | 0.00% | – |
| Q1 2016 | $37,000 | -61.5% | 68,704 | -12.2% | 0.00% | – |
| Q4 2015 | $96,000 | -16.5% | 78,268 | -0.2% | 0.00% | – |
| Q3 2015 | $115,000 | -34.3% | 78,455 | -12.3% | 0.00% | – |
| Q2 2015 | $175,000 | +28.7% | 89,479 | +18.1% | 0.00% | – |
| Q1 2015 | $136,000 | +806.7% | 75,754 | +1117.3% | 0.00% | – |
| Q4 2014 | $15,000 | 0.0% | 6,223 | +0.8% | 0.00% | – |
| Q3 2014 | $15,000 | -44.4% | 6,171 | -35.3% | 0.00% | – |
| Q2 2014 | $27,000 | – | 9,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,425,000 | $3,363,000 | 2.66% |
| ACUTA CAPITAL PARTNERS, LLC | 1,228,111 | $2,898,000 | 1.96% |
| Sio Capital Management, LLC | 505,000 | $1,192,000 | 0.94% |
| RA Capital Management | 2,500,000 | $5,900,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,000 | $1,770,000 | 0.30% |
| TFS CAPITAL LLC | 1,295,744 | $3,058,000 | 0.29% |
| EAGLE ASSET MANAGEMENT INC | 12,713,051 | $30,002,000 | 0.17% |
| JW Asset Management, LLC | 52,271 | $123,000 | 0.09% |
| Lombard Odier Asset Management (USA) Corp | 501,444 | $1,183,000 | 0.08% |
| First Heartland Consultants, Inc. | 74,624 | $176,000 | 0.07% |